Home | Consumers | GlaxoSmithKline to Pay $750M Fine for Sale of Bad Drugs

GlaxoSmithKline to Pay $750M Fine for Sale of Bad Drugs

Font size: Decrease font Enlarge font
Share
Another day, another hard pill to swallow for GlaxoSmithKline.

On Tuesday, the pharmaceutical giant agreed to pay $750 million to settle a government lawsuit alleging that the company sold defective and potentially dangerous medication.

The U.S. Justice Department brought suit against GSK after finding that the company's Cidra, Puerto Rico, factory produced drugs sold to consumers that were often mislabeled, of the wrong dosage and contaminated with micro-organisms.
Rate this article:
0
  • email Email to a friend
  • print Print version
  • Plain text Plain text

Comments (2 posted):

dirty quotes on 09/12/11 03:29:59
avatar
Very important text content. the information quoted is difficult to trust and I loved how wonderful things to offer here.
Web Design Company on 12/18/11 01:08:35
avatar
Really great news. Fine is really a big too. As we all know that bad is always bad and a time come when that bad come to the eye of world like such one. I would like to say that "Stop to play with human health".

Post your comment comment

Please enter the code you see in the image:

Access restricted articles free
TheSafetyChannel
To show your safety related video, Contact Us.
Protecting public health through food safety and defence.
What Simon says about...


Monthly Newsletter
Email:
Supporting SafetyIssues
If you support this website, please consider making a donation and help us continue providing this free service.
Please consider making a donation
Tags
No tags for this article